Precancerous blood disorder raises risk of inflammatory heart disease

New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation.

Study identifies medical conditions that could predict future Alzheimer’s disease

The findings could suggest ways to intervene before clinical symptoms of memory and cognitive impairment become apparent.

Patients with clonal hematopoiesis have increased heart disease risk following cancer treatment 

Study supports the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications.

Study identifies potential target for blood cancer treatment, prevention

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.

Annet Kirabo named “Top Scholar” in hypertension

Martha Dudek receives Strategic Leader Award from National Society of Genetic Counselors

This award honors a genetic counselor who “advances genetic counseling as a vital part of health care through education, research or public policy.